Laboratory Corporation of America Holdings
NYSE:LH
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
191.8992
246.22
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Laboratory Corporation of America Holdings
Laboratory Corporation of America Holdings
Accounts Receivables
Laboratory Corporation of America Holdings
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Accounts Receivables
$2.2B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
1%
|
CAGR 10-Years
10%
|
|
|
DaVita Inc
NYSE:DVA
|
Accounts Receivables
$2.3B
|
CAGR 3-Years
4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
4%
|
|
|
Chemed Corp
NYSE:CHE
|
Accounts Receivables
$196.5m
|
CAGR 3-Years
18%
|
CAGR 5-Years
11%
|
CAGR 10-Years
4%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Accounts Receivables
$1.4B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
4%
|
|
|
CVS Health Corp
NYSE:CVS
|
Accounts Receivables
$9.9B
|
CAGR 3-Years
6%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-1%
|
|
|
Cigna Corp
NYSE:CI
|
Accounts Receivables
$27.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Laboratory Corporation of America Holdings
Glance View
Laboratory Corporation of America Holdings, commonly referred to as LabCorp, has established itself as a leader in the biomedical testing and diagnostics industry. Founded in 1971, the company operates with a mission to improve health and improve lives by providing critical laboratory services to healthcare providers, pharmaceutical companies, and patients. LabCorp offers a comprehensive range of tests, encompassing everything from routine blood work to complex genomic testing. This diverse portfolio positions LabCorp to benefit from the growing demand for diagnostic services, particularly as healthcare continues to evolve toward precision medicine and personalized care. For investors, LabCorp's strategic initiatives and strong financial performance paint a compelling picture. The company has successfully expanded through a series of acquisitions, enhancing its capabilities and market reach. With a focus on innovation, LabCorp has invested heavily in advanced technologies and digital solutions to streamline operations and enhance customer experience. As the healthcare landscape shifts toward value-based care, LabCorp is well-positioned to capture market share and drive revenue growth. With a history of consistent earnings and a commitment to shareholder value, LabCorp represents a potentially attractive investment for those looking to engage in the evolving healthcare sector.
See Also
What is Laboratory Corporation of America Holdings's Accounts Receivables?
Accounts Receivables
2.2B
USD
Based on the financial report for Sep 30, 2024, Laboratory Corporation of America Holdings's Accounts Receivables amounts to 2.2B USD.
What is Laboratory Corporation of America Holdings's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
10%
Over the last year, the Accounts Receivables growth was 8%. The average annual Accounts Receivables growth rates for Laboratory Corporation of America Holdings have been -10% over the past three years , 1% over the past five years , and 10% over the past ten years .
You don't have any saved screeners yet
